Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors

Roulstone, V, Khan, K, Pandha, HS et al. (8 more authors) (2015) Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors. Clinical Cancer Research, 21 (6). 1305 - 1312. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
  • Roulstone, V
  • Khan, K
  • Pandha, HS
  • Rudman, S
  • Coffey, M
  • Gill, GM
  • Melcher, AA
  • Vile, R
  • Harrington, KJ
  • De Bono, J
  • Spicer, J
Dates:
  • Published: March 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Oct 2015 14:48
Last Modified: 03 Nov 2016 08:01
Published Version: http://dx.doi.org/10.1158/1078-0432.CCR-14-1770
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1078-0432.CCR-14-1770
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics